We are delighted by today's decision to allow patients with advanced prostate cancer to receive abiraterone on the NHS.
This drug was discovered at the Institute of Cancer Research and is the result of more than two decades of dedicated work by our scientists and and collaborators.
In clinical trials of men with advanced prostate cancer who have already tried chemotherapy, it has been shown to extend life by an average of four months and improve quality of life.
More top news
Ministry of Defence investigating allegations that members of the British Army shouted sexist abuse watching England Women football team.
The US space agency NASA's Dawn spacecraft has become the first mission to achieve orbit around a dwarf planet.
Comedian Peter Kay has said he is "thrilled" to star in a adaptation of broadcaster Danny Baker's autobiography.